Menière's disease also called endolymphatic hydrops, is a disorder of the inner ear that can affect hearing andbalance.Menière's disease is defined by the association of 4 symptoms: vertigo attacks, fluctuating hearing loss, tinnitus and an auricular plenitude sensation.The treatment of the acute phase of Menière's disease is basically symptomatic.
It is characterized by episodes of vertigo, tinnitus, and hearing loss. The hearing loss comes and goes for some time, alternating between ears, then becomes permanent. The pathophysiology is explained by a distension of membranous labyrinth by the endolymph, equally called endolymphatic hydrops.
Meniere’s disease affects one in every 600 Australians. It appears that Meniere’s is diagnosed around late thirties to early fifties. It is uncommon for children to be diagnosed. Unfortunately this is a time of life when people are busy with family and careers.Long term management of Menière's disease includes a low salt diet.
The treatment is medical in the majority of patients but there is no international consensus on the management of the different stages of Menière's disease. Regarding the lack of clinical studies clearly demonstrating the effectiveness of a certain therapy or another.The recommendations are usually based on the empirical experience of practitioners.
Major research on disease:
"Pathophysiology of Ménière’s Syndrome: Are Symptoms Caused by Endolymphatic Hydrops".Vestibular suppressant drugs have a well-established record in controlling acute attacks of vertigo. Most have variable anticholinergic, anti-emetic and vestibular sedative effects. If necessary, the administration of benzodiazepines will help to alleviate anxiety.